Lovelace Biomedical

Lovelace Biomedical

Pharmaceutical Manufacturing

Albuquerque, NM 2,690 followers

Preclinical drug development, multiple scientific expertise, and extensive history

About us

Building on a history of pioneering science and technological innovation, Lovelace Biomedical is a contract research organization that helps pharmaceutical and biotechnology companies advance their discoveries—no matter how complex—into clinical testing and beyond. The organization leverages a multidisciplinary toolset to push the limits of preclinical research and fully understand the behavior of its clients’ investigational products. Lovelace Biomedical provides a unique experimental breadth and logistical capacity to solve specialized challenges that other CROs are not equipped to handle, featuring expansive bio-secure facilities and ongoing access to industry-leading scientific experts. The team thrives on developing programs for complex diseases, emerging drug classes and delivery mechanisms, and challenging areas of drug development while delivering the same level of rigor and attention to seemingly straightforward studies that are just as critical to regulatory success.

Website
http://www.lovelacebiomedical.org
Industry
Pharmaceutical Manufacturing
Company size
501-1,000 employees
Headquarters
Albuquerque, NM
Type
Nonprofit
Founded
1947
Specialties
Biotechnology, Pharmaceuticals, Preclinical Research, Toxicology, Pharmacology, Safety and Efficacy, Bioanalytical Services, Pharmacokinetics and Biodistribution, Inhalation, Respiratory Disease, Gene Therapy, Infectious Disease, and Colony Maintenance

Locations

Employees at Lovelace Biomedical

Updates

  • View organization page for Lovelace Biomedical, graphic

    2,690 followers

    If you have not had a chance to visit our laboratory, here is a snapshot of who we are and what we do. We are a preclinical toxicology contract research facility with a rich 70-year legacy of excellence in animal models and toxicology (https://lnkd.in/gjkpCUis). We focus on technical competence and service in our areas of excellence in gene/cell therapy, respiratory, immunology, and infectious disease. Take a look! ⬇️  View the video below for insight into our institute and learn more.

  • View organization page for Lovelace Biomedical, graphic

    2,690 followers

    Are you interested in the latest advancements in intranasal drug delivery? Join us for an AAPS eChalk Talk on August 21st, 2024 to explore the challenges and opportunities in this growing field! Intranasal drug delivery is a rapidly evolving area of pharmaceutical research. This session will provide valuable insights for anyone involved in non-clinical drug development. Leading the discussion is Philip Kuehl, Ph.D., who has extensive experience in pulmonary formulation and respiratory drug development. Space is limited, so register now to secure your spot! https://bityl.co/QztY

    • No alternative text description for this image
  • View organization page for Lovelace Biomedical, graphic

    2,690 followers

    Lovelace Biomedical is proud to sponsor this year’s Association of Inhalation Toxicologists conference: “Inhalation Toxicology Rocks!” Deep dive into cutting-edge science with the conference addressing: 🔬NAMs & disease modeling 🔬Inhaled biologics & gene therapies 🔬Intranasal drug delivery 🔬Wildfire smoke inhalation & more! Plus, attending for the first time or renewing your membership grants you 3 years of access to the AIT member's area—including past conference recordings and presentations! Registration is open now, so sign up today: https://lnkd.in/gcf9GvxM

    • No alternative text description for this image
  • View organization page for Lovelace Biomedical, graphic

    2,690 followers

    Unlock the potential of your drug candidates with Lovelace Biomedical's integrated approach to pharmacology. Our state-of-the-art facilities and experienced scientists conduct thorough pharmacokinetic and pharmacodynamic assessments, guiding informed decisions throughout the drug development process. Partner with us to accelerate therapeutic discoveries: https://bityl.co/NTZc

    • No alternative text description for this image
  • View organization page for Lovelace Biomedical, graphic

    2,690 followers

    Lovelace Biomedical has an over 70-year history in the area of respiratory drug delivery. Throughout this history, the question of how do you build relationships between non-clinical and clinical dose have always come up. Philip Kuehl is a co-author on a recent article published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery (https://bityl.co/PdPU) that details this process in a direct manner. If you wish to learn more about inhalation dosimetry between species, reach out to an expert at Lovelace Biomedical. https://bityl.co/NTZc

    • No alternative text description for this image

Similar pages

Browse jobs